Concepedia

Keisuke Shirai

KS

57

Publications

5K

Citations

33

H-Index

2005

Active since

Affiliations

Medical University of South Carolina(Current)

Dartmouth–Hitchcock Medical Center

MUSC Hollings Cancer Center

The University of Texas MD Anderson Cancer Center

Roswell Park Comprehensive Cancer Center

Keisuke Shirai is an author at Medical University of South Carolina specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2005–2024

57

Publications

57

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry et al. · JAMA · 2014 · 1.7K citations · Full text

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant

Naoka Murakami, Patrick M. Mulvaney, Melissa Danesh et al. · Kidney International · 2020 · 168 citations · Full text

, , +11

Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma

Muhammad Zubair Afzal, Rima R. Mercado, Keisuke Shirai · Journal for ImmunoTherapy of Cancer · 2018 · 164 citations · Full text

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Carolyn D. Britten, Elizabeth Garrett‐Mayer, Steven Chin et al. · Clinical Cancer Research · 2017 · 159 citations · Full text

Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma

Aleksey Molodtsov, Nikhil Khatwani, Jennifer L. Vella et al. · Immunity · 2021 · 158 citations · Full text

, , +9

Rows per page

1–5 of 57